Abstract:In recent years, with the rapid increase in the volume and accessibility of Real-World-Data (RWD) and Real-World-Evidence (RWE), we have seen the unprecedented opportunities for their use in drug clinical development and life-cycle management. RWD and RWE have demonstrated the significant potential to improve the design, planning, and execution of clinical development. Furthermore, they can feature in the designs as either a substitute or compliment to traditional clinical trials. However, to utilize RWD and RWE appropriately and wisely, it is critical to apply rigorous statistical methodologies that enable the robustness of results to be characterized and ascertained. Several statistical methodologies including exact matching, propensity score methods, matching-adjusted indirect comparisons and meta-analysis have been proposed for analyzing RWD. Among them, propensity score method is one of the most commonly used methods for non-randomized trials with indirect comparison. Although massive methodologies and examples have been published and discussed since propensity score methods were introduced, systematic review and discussion of how to rigorously use propensity score methods in the practical clinical development is still deficient. This paper introduces commonly used and emerging propensity score methods with detailed discussions of their pros and cons. Three different case studies are presented to illustrate the practical considerations of utilizing propensity score methods in the study design and evaluation using real-world and historical data. Additional considerations including selection of patient populations, endpoints, baseline covariates, propensity score methods, sensitivity analysis and practical implementation flow in clinical development will be discussed.

Propensity Score Methods for Merging Observational and Experimental Datasets

Propensity Score Methods for Creating Covariate Balance in Observational Studies

Adaptive Combination of Randomized and Observational Data

Augmenting treatment arms with external data through propensity-score weighted power-priors: an application in expanded access

Using Propensity Scores to Estimate Effects of Treatment Initiation Decisions: State of the Science

Triangulating Instrumental Variable, confounder adjustment and Difference-in-Difference methods for comparative effectiveness research in observational data

Estimating Heterogeneous Treatment Effects by Combining Weak Instruments and Observational Data

Propensity Score Augmentation in Matching-based Estimation of Causal Effects

Practical Considerations of Utilizing Propensity Score Methods in Clinical Development Using Real-World and Historical Data

Contrast-specific Propensity Scores for Causal Inference with Multiple Interventions.

Estimating Causal Effects from Large Data Sets Using Propensity Scores

Propensity Score Analysis in Non-Randomized Experimental Designs: An Overview and a Tutorial Using R Software

Long-term effect estimation when combining clinical trial and observational follow-up datasets

A propensity score‐integrated approach for leveraging external data in a randomized controlled trial with time‐to‐event endpoints

Analyzing Treatment Effect by Integrating Existing Propensity Score and Outcome Regressions with Heterogeneous Covariate Sets

Propensity score weighted multi‐source exchangeability models for incorporating external control data in randomized clinical trials

Bayesian propensity scores for high-dimensional causal inference: A comparison of drug-eluting to bare-metal coronary stents

Recent Development Of Propensity Score Methods In Observational Studies: Multi-Categorical Treatment, Causal Mediation, And Heterogeneity

Estimating and Using Propensity Scores with Partially Missing Data

Comparing methods for estimation of heterogeneous treatment effects using observational data from health care databases